SENP7
Sentrin-specific protease 7
Also known as: SENP7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BQF6
- Gene
- SENP7
- Ensembl
- ENSG00000138468
- Chromosome
- 3
- Canonical length
- 1050 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Centrosome,Cytosol
OverviewNCBI Gene
The reversible posttranslational modification of proteins by the addition of small ubiquitin-like SUMO proteins (see SUMO1; MIM 601912) is required for many cellular processes. SUMO-specific proteases, such as SENP7, process SUMO precursors to generate a C-terminal diglycine motif required for the conjugation reaction. They also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]).[supplied by OMIM, Jun 2009]
Canonical amino-acid sequenceUniProt
1050 residues, UniProt reviewed canonical sequence.
>Q9BQF6|SENP7
1 MDKRKLGRRP SSSEIITEGK RKKSSSDLSE IRKMLNAKPE DVHVQSPLSK FRSSERWTLP
61 LQWERSLRNK VISLDHKNKK HIRGCPVTSK SSPERQLKVM LTNVLWTDLG RKFRKTLPRN
121 DANLCDANKV QSDSLPSTSV DSLETCQKLE PLRQSLNLSE RIPRVILTNV LGTELGRKYI
181 RTPPVTEGSL SDTDNLQSEQ LSSSSDGSLE SYQNLNPHKS CYLSERGSQR SKTVDDNSAK
241 QTAHNKEKRR KDDGISLLIS DTQPEDLNSG SRGCDHLEQE SRNKDVKYSD SKVELTLISR
301 KTKRRLRNNL PDSQYCTSLD KSTEQTKKQE DDSTISTEFE KPSENYHQDP KLPEEITTKP
361 TKSDFTKLSS LNSQELTLSN ATKSASAGST TETVENSNSI DIVGISSLVE KDENELNTIE
421 KPILRGHNEG NQSLISAEPI VVSSDEEGPV EHKSSEILKL QSKQDRETTN ENESTSESAL
481 LELPLITCES VQMSSELCPY NPVMENISSI MPSNEMDLQL DFIFTSVYIG KIKGASKGCV
541 TITKKYIKIP FQVSLNEISL LVDTTHLKRF GLWKSKDDNH SKRSHAILFF WVSSDYLQEI
601 QTQLEHSVLS QQSKSSEFIF LELHNPVSQR EELKLKDIMT EISIISGELE LSYPLSWVQA
661 FPLFQNLSSK ESSFIHYYCV STCSFPAGVA VAEEMKLKSV SQPSNTDAAK PTYTFLQKQS
721 SGCYSLSITS NPDEEWREVR HTGLVQKLIV YPPPPTKGGL GVTNEDLECL EEGEFLNDVI
781 IDFYLKYLIL EKASDELVER SHIFSSFFYK CLTRKENNLT EDNPNLSMAQ RRHKRVRTWT
841 RHINIFNKDY IFVPVNESSH WYLAVICFPW LEEAVYEDFP QTVSQQSQAQ QSQNDNKTID
901 NDLRTTSTLS LSAEDSQSTE SNMSVPKKMC KRPCILILDS LKAASVQNTV QNLREYLEVE
961 WEVKLKTHRQ FSKTNMVDLC PKVPKQDNSS DCGVYLLQYV ESFFKDPIVN FELPIHLEKW
1021 FPRHVIKTKR EDIRELILKL HLQQQKGSSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SENP7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 25 nTPM
- retina: 24 nTPM
- ovary: 23 nTPM
- lymph node: 21 nTPM
- bone marrow: 21 nTPM
- skin: 19 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 235 nCPM
- podocytes: 225 nCPM
- neutrophils: 222 nCPM
- lactotrophs: 216 nCPM
- pituicytes/fscs: 211 nCPM
- gonadotrophs: 208 nCPM
Immune cell
- basophil: 42 nTPM
- neutrophil: 16 nTPM
- naive CD4 T-cell: 10 nTPM
- NK-cell: 8.8 nTPM
- naive B-cell: 8.5 nTPM
- memory CD4 T-cell: 7.5 nTPM
Brain region
- cerebellum: 51 nTPM
- white matter: 47 nTPM
- medulla oblongata: 37 nTPM
- pons: 37 nTPM
- hypothalamus: 34 nTPM
- basal ganglia: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SENP7.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 137 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- arthrogryposis multiplex congenita with neutropenia and early respiratory failure
- Arthrogryposis Multiplex Congenita and Immunodeficiency
- SENP7-associated disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 2.12
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SENP7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SENP7 as an antibody target. Whether an autoantibody or antibody against SENP7 could matter depends on whether native SENP7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SENP7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SENP7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...